145 related articles for article (PubMed ID: 21598248)
1. Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression.
Rajan N; Burn J; Langtry J; Sieber-Blum M; Lord CJ; Ashworth A
J Pathol; 2011 Jul; 224(3):309-21. PubMed ID: 21598248
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.
Rajan N; Elliott R; Clewes O; Mackay A; Reis-Filho JS; Burn J; Langtry J; Sieber-Blum M; Lord CJ; Ashworth A
Oncogene; 2011 Oct; 30(41):4243-60. PubMed ID: 21552290
[TBL] [Abstract][Full Text] [Related]
3. Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.
Tauriello DV; Haegebarth A; Kuper I; Edelmann MJ; Henraat M; Canninga-van Dijk MR; Kessler BM; Clevers H; Maurice MM
Mol Cell; 2010 Mar; 37(5):607-19. PubMed ID: 20227366
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells.
Rajan N; Andersson MK; Sinclair N; Fehr A; Hodgson K; Lord CJ; Kazakov DV; Vanecek T; Ashworth A; Stenman G
J Pathol; 2016 Jun; 239(2):197-205. PubMed ID: 26969893
[TBL] [Abstract][Full Text] [Related]
5. Inherited cylindromas: lessons from a rare tumour.
Rajan N; Ashworth A
Lancet Oncol; 2015 Sep; 16(9):e460-e469. PubMed ID: 26370355
[TBL] [Abstract][Full Text] [Related]
6. CYLD tidies up dishevelled signaling.
Komander D
Mol Cell; 2010 Mar; 37(5):589-90. PubMed ID: 20227361
[TBL] [Abstract][Full Text] [Related]
7. Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/β-Catenin Signaling.
Wang C; Yue Y; Shao B; Qiu Z; Mu J; Tang J; Han X; Xiang T; Ren G
Cell Physiol Biochem; 2017; 41(5):1709-1724. PubMed ID: 28365691
[TBL] [Abstract][Full Text] [Related]
8. ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma.
Rashid M; van der Horst M; Mentzel T; Butera F; Ferreira I; Pance A; Rütten A; Luzar B; Marusic Z; de Saint Aubain N; Ko JS; Billings SD; Chen S; Abi Daoud M; Hewinson J; Louzada S; Harms PW; Cerretelli G; Robles-Espinoza CD; Patel RM; van der Weyden L; Bakal C; Hornick JL; Arends MJ; Brenn T; Adams DJ
Nat Commun; 2019 May; 10(1):2213. PubMed ID: 31101826
[TBL] [Abstract][Full Text] [Related]
9. Spiradenocylindrocarcinoma: a malignant hybrid tumor.
Carlsten JR; Lewis MD; Saddler K; Reilly P; Pan T; Gnepp DR; Robinson-Bostom L
J Cutan Pathol; 2005 Feb; 32(2):166-71. PubMed ID: 15606677
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma ex spiradenoma/cylindroma confirmed by immunohistochemical and molecular loss-of-heterozygosity profiling.
Jukic DM; Drogowski LM; Davie JR
Am J Dermatopathol; 2009 Oct; 31(7):702-8. PubMed ID: 19684510
[TBL] [Abstract][Full Text] [Related]
11. Spiradenocylindromas of the skin: tumors with morphological features of spiradenoma and cylindroma in the same lesion: report of 12 cases.
Michal M; Lamovec J; Mukensnabl P; Pizinger K
Pathol Int; 1999 May; 49(5):419-25. PubMed ID: 10417685
[TBL] [Abstract][Full Text] [Related]
12. Dickkopf-related protein 2 induces G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin signaling and is frequently methylated in breast cancer.
Mu J; Hui T; Shao B; Li L; Du Z; Lu L; Ye L; Li S; Li Q; Xiao Q; Qiu Z; Zhang Y; Fan J; Ren G; Tao Q; Xiang T
Oncotarget; 2017 Jun; 8(24):39443-39459. PubMed ID: 28467796
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells.
Xiang T; Li L; Yin X; Zhong L; Peng W; Qiu Z; Ren G; Tao Q
J Cell Mol Med; 2013 Oct; 17(10):1236-46. PubMed ID: 23890219
[TBL] [Abstract][Full Text] [Related]
14. Brooke-Spiegler syndrome associated with cylindroma, trichoepithelioma and eccrine spiradenoma.
Chen M; Liu H; Fu X; Yu Y; Yu G; Tian H; Zhou G; Lu X; Chen S
Int J Dermatol; 2013 Dec; 52(12):1602-4. PubMed ID: 24261740
[No Abstract] [Full Text] [Related]
15. Cylindroma and eccrine spiradenoma coexistent in the same lesion.
Goette DK; McConnell MA; Fowler VR
Arch Dermatol; 1982 Apr; 118(4):274-4. PubMed ID: 6279036
[TBL] [Abstract][Full Text] [Related]
16. Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission.
Arefi M; Wilson V; Muthiah S; Zwolinski S; Bajwa D; Brennan P; Blasdale K; Bourn D; Burn J; Santibanez-Koref M; Rajan N
J Am Acad Dermatol; 2019 Dec; 81(6):1300-1307. PubMed ID: 31085270
[TBL] [Abstract][Full Text] [Related]
17. Spiradenoma and cylindroma originate from the hair follicle bulge and not from the eccrine sweat gland: an immunohistochemical study with CD200 and other stem cell markers.
Sellheyer K
J Cutan Pathol; 2015 Feb; 42(2):90-101. PubMed ID: 25354097
[TBL] [Abstract][Full Text] [Related]
18. [Multiple trichoepithelioma, cylindroma, eccrine spiradenoma present in the same family. Histologic and histopathogenetic considerations].
Cecchi R; Crudeli F; Fedi E; Giomi A
G Ital Dermatol Venereol; 1985; 120(2):149-52. PubMed ID: 2989163
[No Abstract] [Full Text] [Related]
19. Expression of p53 and TP53 mutational analysis in malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma, sporadic or associated with Brooke-Spiegler syndrome.
Kazakov DV; Grossmann P; Spagnolo DV; Vanecek T; Vazmitel M; Kacerovska D; Zelger B; Calonje E; Michal M
Am J Dermatopathol; 2010 May; 32(3):215-221. PubMed ID: 20075707
[TBL] [Abstract][Full Text] [Related]
20. Magnifying glass on spiradenoma and cylindroma histogenesis and tumorigenesis using systematic transcriptome analysis.
Bell AH; Prieto VG; Ferrarotto R; Goepfert RP; Myers JN; Weber R; Bell D
Ann Diagn Pathol; 2019 Aug; 41():14-23. PubMed ID: 31128548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
